Cite

HARVARD Citation

    DiazGranados, C. et al. (2015). Safety and immunogenicity of high-dose trivalent inactivated influenza vaccine in adults 50–64 years of age. Vaccine. 33 (51), pp. 7188-7193. [Online]. 
  
Back to record